Previous 10 | Next 10 |
The Ark Innovation ETF was fallen 60% from its high water mark, far more than 10%ish drop of the handful of growth stocks which top the S&P 500 and NASDAQ100. Charts and tables for price and AUM show clearly the the majority of investors in ARKK bought at the top; most ARKK holder...
Invitae Corporation (NVTA) Cowen 42nd Annual Healthcare Conference March 07, 2022 11:00 AM ET Company Participants Sean George - CEO Conference Call Participants Dan Brennan - Cowen and Company Presentation Dan Brennan Good morning. Dan Brennan here from Cowen’s Life Science, Tools &am...
Invitae announces $400 million potential equity sales program. Invitae's cash burn to be at least $600 million in 2022. NVTA's outstanding share count could surge from here. For further details see: Invitae Drops On Potential Major Dilution
The following slide deck was published by Invitae Corporation in conjunction with their 2021 Q4 earnings call. For further details see: Invitae Corporation 2021 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Invitae (NYSE: NVTA) Q4 2021 Earnings Call Feb 24, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Invitae (NVTA) Q4 2021 Earnings Call Transcript
Invitae Corporation (NVTA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Jack Finks – Investor Relations Sean George – Chief Executive Officer Roxi Wen – Chief Financial Officer Ken Knight – Chief Operating Officer Conference Ca...
Although Invitae (NYSE:NVTA) saw its Q4 2021 net loss narrow 12% compared to the prior-year period, the company still missed consensus on the bottom line. Net loss declined to $205.1M in the quarter. Net loss per share in the quarter was -$0.90, an improvement from -$1.30 in Q4 2020. Revenue ...
Invitae press release (NYSE:NVTA): Q4 Non-GAAP EPS of -$0.81 misses by $0.04. Revenue of $126.1M (+25.6% Y/Y) beats by $0.2M. Shares -0.43% AH Guidance: The company has issued 2022 annual revenue guidance of year-over-year revenue growth of 40 percent, or approximately $640 million. New ...
Invitae Reports $460.4 Million in Annual Revenue Driven by 1.17 Million in Billable Volume in 2021 -- Annual revenue grew by 65 percent and annual billable volume by 77 percent year over year -- -- Full-year 2022 revenue growth guidance of 40 percent to approximately $640 mi...
Invitae (NYSE:NVTA) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close. The consensus EPS Estimate is -$0.77 (-22.2% Y/Y) and the consensus Revenue Estimate is $125.9M (+25.4% Y/Y). Over the last 2 years, NVTA has beaten EPS estimates 25% of the time a...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...